Chongqing Zhifei Biological Products News

Zhifei Biotech: 2025-02 2024 Annual Performance Forecast

Jan 24 19:42

Zhifei Biotech: Announcement on acceptance of clinical trial application for trivalent influenza virus lysis vaccine (ZFA02 adjuvant)

Jan 6 18:53

Zhifei Biotech: 2024 Interim Equity Distribution Implementation Notice

Dec 17, 2024 20:16

Zhifei Biotech: Announcement on optimizing and adjusting strategic cooperation with GSK

Dec 5, 2024 17:54

Zhifei Biotech: Announcement of Resolutions of the Third Meeting of the 6th Board of Directors

Dec 5, 2024 17:54

Zhifei Biotech: Investor Relations Activity Record Form

Nov 28, 2024 18:00

Zhifei Biotech: Announcement on the Continued Inclusion of Recombinant Mycobacterium Tuberculosis Fusion Protein (EC) in the National Medical Insurance Catalogue

Nov 28, 2024 16:56

Zhifei Biotech: Announcement on participating in the 2024 Online Investor Group Reception Day for Listed Companies under the jurisdiction of Chongqing

Nov 21, 2024 18:30

Zhifei Biotech: Investor Relations Activity Record Form

Oct 30, 2024 19:28

Zhifei Biotech: Announcement on the 2024 Mid-Term Profit Distribution Plan

Oct 26, 2024 00:00

Zhifei Biotech: Announcement on acceptance of the application for production registration of the influenza virus lysis vaccine

Oct 26, 2024 00:00

Zhifei Biotech: Announcement of Resolutions of the 2nd Meeting of the 6th Board of Directors

Oct 26, 2024 00:00

Zhifei Biotech: Report for the third quarter of 2024

Oct 26, 2024 00:00

Zhifei Biotech: Announcement of Resolutions of the 2nd Meeting of the 6th Board of Supervisors

Oct 26, 2024 00:00

Zhifei Biotech: Announcement on the approval notice for the quadrivalent influenza virus lysis vaccine (ZFA02 adjuvant) for clinical trials

Oct 26, 2024 00:00

Zhifei Biotech: Announcement on acceptance of the application for production registration for freeze-dried human rabies vaccine (human diploid cells)

Oct 16, 2024 18:42

Zhifei Biotech: Announcement on acceptance of the application for production registration of the quadrivalent influenza virus lysis vaccine (pediatric type)

Oct 9, 2024 18:48

Zhifei Biotech: Announcement on the pledge of some of the shares of the company\'s controlling shareholder

Sep 27, 2024 18:42

Zhifei Biotech: Announcement of Resolutions of the First Meeting of the 6th Board of Directors

Sep 20, 2024 21:28

Zhifei Biotech: Announcement on the completion of the Board of Directors and Supervisory Board changes and the departure of some directors and senior management at the end of their term

Sep 20, 2024 21:24